Letter to the editor: Leveraging universal adult vaccination as part of a multipronged approach to eliminate hepatitis B in the USA
Vivian Huang, Clem Lewin, Patricia Novy – 30 January 2022
Intraoperative risk factors of acute kidney injury after liver transplantation
Rachel J. Berkowitz, Milo C. Engoren, Graciela Mentz, Pratima Sharma, Sathish S. Kumar, Ryan Davis, Sachin Kheterpal, Christopher J. Sonnenday, Nicholas J. Douville – 30 January 2022 – Acute kidney injury (AKI) is one of the most common complications of liver transplantation (LT). We examined the impact of intraoperative management on risk for AKI following LT. In this retrospective observational study, we linked data from the electronic health record with standardized transplant outcomes.
Cerium oxide nanoparticles administration during machine perfusion of discarded human livers: A pilot study
Serena Del Turco, Valentina Cappello, Christos Tapeinos, Aldo Moscardini, Laura Sabatino, Matteo Battaglini, Fabio Melandro, Francesco Torri, Caterina Martinelli, Serena Babboni, Beatrice Silvestrini, Riccardo Morganti, Mauro Gemmi, Paolo De Simone, Paulo N. Martins, Laura Crocetti, Adriano Peris, Daniela Campani, Giuseppina Basta, Gianni Ciofani, Davide Ghinolfi – 30 January 2022 – The combined approach of ex situ normothermic machine perfusion (NMP) and nanotechnology represents a strategy to mitigate ischemia/reperfusion injury in liver transplantation (LT).
Reply
Ya Deng, Chun‐Yan Wang, Xiao‐Xia Niu, Dong Ji – 30 January 2022
Shared and Data‐Driven Decision‐Making with Transplant Recipients About COVID‐19 Vaccination Is Crucial
Alexandra T. Strauss, Dorry L. Segev, William A. Werbel – 29 January 2022
Portal vein complications and outcomes following pediatric liver transplantation: Data from the Society of Pediatric Liver Transplantation
James P. Stevens, Yijin Xiang, Traci Leong, Kushal Naik, Nitika Arora Gupta – 28 January 2022 – Children who undergo liver transplantation are at risk for portal vein complications (PVCs) including thrombosis (PVT) and stenosis (PVS). Using multicenter data from the Society of Pediatric Liver Transplantation, we analyzed the prevalence, timing, and risk factors for PVC following a first liver transplantation, and assessed the potential impact of PVC on patient outcomes. Our cohort included 4278 patients, of whom 327 (7.6%) developed PVC.
Surveillance Biopsies in Pediatric Liver Transplantation: Is the Juice Worth the Squeeze?
James E. Squires, Anthony J. Demetris – 28 January 2022
Contrast‐enhanced CT and liver surface nodularity for the diagnosis of porto‐sinusoidal vascular disorder: A case‐control study
Shantha Ram Valainathan, Riccardo Sartoris, Laure Elkrief, Marta Magaz, Fabian Betancourt, Silvia Pellegrino, Arianna Nivolli, Marco Dioguardi Burgio, Yves Flattet, Sylvain Terraz, Nicolas Drilhon, Marie Lazareth, Julia Herrou, Onorina Bruno, Audrey Payance, Aurélie Plessier, François Durand, Maxime Ronot, Dominique‐Charles Valla, Valérie Paradis, Juan Carlos Garcia‐Pagan, Valérie Vilgrain, Pierre‐Emmanuel Rautou – 28 January 2022
Letter to the editor: In patients with established NASH cirrhosis, is there no role of weight reduction in reversing fibrosis?
Ashish Kumar, Praveen Sharma, Anil Arora – 28 January 2022
Ursodeoxycholic Acid Decreases Incidence of Primary Biliary Cholangitis and Biliary Complications After Liver Transplantation
Mariana C. Zapata, Mark R. Pedersen – 27 January 2022